179 related articles for article (PubMed ID: 22571802)
1. Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms.
Huusko T; Salonurmi T; Taskinen P; Liinamaa J; Juvonen T; Pääkkö P; Savolainen M; Kakko S
J Thorac Cardiovasc Surg; 2013 Apr; 145(4):1117-1123. PubMed ID: 22571802
[TBL] [Abstract][Full Text] [Related]
2. A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2.
Sinha I; Bethi S; Cronin P; Williams DM; Roelofs K; Ailawadi G; Henke PK; Eagleton MJ; Deeb GM; Patel HJ; Berguer R; Stanley JC; Upchurch GR
J Vasc Surg; 2006 Feb; 43(2):342-8. PubMed ID: 16476613
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
Wilton E; Bland M; Thompson M; Jahangiri M
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II Induces an Increase in Matrix Metalloproteinase 2 Expression in Aortic Smooth Muscle Cells of Ascending Thoracic Aortic Aneurysms Through JNK, ERK1/2, and p38 MAPK Activation.
Wang C; Chang Q; Sun X; Qian X; Liu P; Pei H; Guo X; Liu W
J Cardiovasc Pharmacol; 2015 Sep; 66(3):285-93. PubMed ID: 25955575
[TBL] [Abstract][Full Text] [Related]
5. Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms.
Monaco M; Stassano P; Di Tommaso L; Iannelli G
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):925-31. PubMed ID: 17903509
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms.
Schmoker JD; McPartland KJ; Fellinger EK; Boyum J; Trombley L; Ittleman FP; Terrien C; Stanley A; Howard A
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):155-61. PubMed ID: 17198804
[TBL] [Abstract][Full Text] [Related]
7. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of TIMPs in ascending aorta aneurysms.
Tsarouhas K; Soufla G; Apostolakis S; Zaravinos A; Panagiotou M; Khoury M; Hassoulas JA; Tsatsakis AM; Spandidos DA
Thromb Res; 2010 Nov; 126(5):399-405. PubMed ID: 20863553
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
LeMaire SA; Wang X; Wilks JA; Carter SA; Wen S; Won T; Leonardelli D; Anand G; Conklin LD; Wang XL; Thompson RW; Coselli JS
J Surg Res; 2005 Jan; 123(1):40-8. PubMed ID: 15652949
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves.
Ikonomidis JS; Jones JA; Barbour JR; Stroud RE; Clark LL; Kaplan BS; Zeeshan A; Bavaria JE; Gorman JH; Spinale FG; Gorman RC
J Thorac Cardiovasc Surg; 2007 Apr; 133(4):1028-36. PubMed ID: 17382648
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
[TBL] [Abstract][Full Text] [Related]
12. Spatial differences of matrix metalloproteinase-2 and matrix metalloproteinase-9 within abdominal aortic aneurysm wall and intraluminal thrombus.
Siennicka A; Zuchowski M; Kaczmarczyk M; Cnotliwy M; Clark JS; Jastrzebska M
J Physiol Pharmacol; 2016 Dec; 67(6):903-910. PubMed ID: 28195071
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Yamashita A; Noma T; Nakazawa A; Saito S; Fujioka K; Zempo N; Esato K
World J Surg; 2001 Mar; 25(3):259-65. PubMed ID: 11343173
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.
Karapanagiotidis GT; Antonitsis P; Charokopos N; Foroulis CN; Anastasiadis K; Rouska E; Argiriadou H; Rammos K; Papakonstantinou C
J Cardiothorac Surg; 2009 Nov; 4():59. PubMed ID: 19886986
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine and metalloprotease-3 and -9 in patients with ascending aorta aneurysms.
Tsarouhas K; Tsitsimpikou C; Apostolakis S; Haliassos A; Tzardi M; Panagiotou M; Tsatsakis A; Spandidos DA
Thromb Res; 2011 Nov; 128(5):e95-9. PubMed ID: 21802713
[TBL] [Abstract][Full Text] [Related]
16. Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease.
Ikonomidis JS; Ivey CR; Wheeler JB; Akerman AW; Rice A; Patel RK; Stroud RE; Shah AA; Hughes CG; Ferrari G; Mukherjee R; Jones JA
J Thorac Cardiovasc Surg; 2013 May; 145(5):1326-33. PubMed ID: 23312977
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.
Hovsepian DM; Ziporin SJ; Sakurai MK; Lee JK; Curci JA; Thompson RW
J Vasc Interv Radiol; 2000; 11(10):1345-52. PubMed ID: 11099248
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm.
Jin D; Sheng J; Yang X; Gao B
Surg Neurol; 2007; 68 Suppl 2():S11-6; discussion S16. PubMed ID: 17714769
[TBL] [Abstract][Full Text] [Related]
19. Influence of cardiovascular risk factors on levels of matrix metalloproteinases 2 and 9 in human abdominal aortic aneurysms.
Dilmé JF; Bellmunt S; Camacho M; Solà-Villà D; Romero JM; Escudero JR; Vila L
Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):374-81. PubMed ID: 24980077
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of connective tissue growth factor, osteopontin and increased collagen content in human ascending thoracic aortic aneurysms.
Meng YH; Tian C; Liu L; Wang L; Chang Q
Vascular; 2014 Feb; 22(1):20-7. PubMed ID: 23508392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
